Senior Counsel – Biotech Patent Law - Biosimilars jobs in United States
cer-icon
Apply on Employer Site
company-logo

Amgen · 4 hours ago

Senior Counsel – Biotech Patent Law - Biosimilars

Amgen is a leading biotechnology company dedicated to serving patients living with serious illnesses. The Senior Counsel will develop and implement market access strategies for biosimilars and innovator molecules, focusing on intellectual property and freedom-to-operate analyses.

BiotechnologyHealth CareManufacturingPharmaceutical
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Handling all aspects of intellectual property, especially in identification of relevant patents, conducting searches for prior art, analyzing third party patents, developing persuasive legal arguments, drafting opinions, working with experts, and performing other pre-litigation activities
Developing and implementing global freedom-to-operate strategies for Amgen products in collaboration with other in-house attorneys
Drafting and prosecuting patent applications and providing patent litigation support
Developing and counseling others on intellectual property strategies associated with Amgen’s business and research endeavors
Working individually, in legal teams, and in cross-functional business teams
10% domestic and global travel anticipated

Qualification

J.D.LL.M. degreeU.S. PatentTrademark Office registrationPatent law experienceIntellectual property law experienceBiotechnology knowledgeLegal drafting skillsAnalytical skillsOralClient counseling skillsWritten communicationTeamwork skills

Required

J.D. degree or LL.M. degree from an accredited law school
Admission to practice law in a U.S. jurisdiction
Four (4) years of experience practicing intellectual property law
Registration to practice before the U.S. Patent and Trademark Office

Preferred

7+ years of experience practicing patent or intellectual property law
Enthusiasm for joining a cutting-edge biosimilar practice group at a leading biotechnology company
Experience in U.S. and/or foreign intellectual property law relating to biotechnology at a law firm or biotechnology/pharmaceutical corporation
Experience in U.S. and/or foreign adversarial proceedings (such as patent litigation, Inter Partes Reviews, Post Grant Reviews, or oppositions), including experience developing and implementing a global freedom-to-operate strategy
Undergraduate degree in the sciences and a working understanding of molecular biology, cell biology, microbiology, biochemistry, genetics, immunology, structural biology, pharmaceutics, or chemical engineering. Preferably, an advanced degree, such as a Master's or Ph.D., or research experience in one of these areas
Excellent judgement, analytical skills, legal drafting and oral and written communication skills
Strong management and client counseling skills
Ability to work independently and in teams, navigate through ambiguity, work efficiently, prioritize workflow, meet fast-paced deadlines, and manage multifaceted projects in a fast-paced environment

Benefits

A comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions, group medical, dental and vision coverage, life and disability insurance, and flexible spending accounts
A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan
Stock-based long-term incentives
Award-winning time-off plans
Flexible work models where possible

Company

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.

H1B Sponsorship

Amgen has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (429)
2024 (485)
2023 (485)
2022 (540)
2021 (460)
2020 (444)

Funding

Current Stage
Public Company
Total Funding
$28.5B
2022-12-12Post Ipo Debt· $28.5B
1983-06-17IPO

Leadership Team

leader-logo
Robert Bradway
Chairman and Chief Executive Officer
linkedin
leader-logo
Jay Bradner
Executive Vice President of R&D, and Chief Scientific Officer
linkedin
Company data provided by crunchbase